Clinical evaluation of therapeutic success in rabbits with suspected encephalitozoonosis

Between 2000 and 2008, 95 rabbits with suspected encephalitozoonosis and neurological symptoms were treated at the Clinic of Small Animal Medicine, Ludwig Maximilian University Munich. Standard treatment consisted of oxytetracycline (from 2000 to 2003; n=50) or fenbendazole and oxytetracycline (from 2004 to 2008; n=45), and the rabbits were randomly assigned to treatment groups with or without dexamethasone. Each therapeutic regime was given for 10 days, with fluids, B vitamins and nutritional support added as needed. Therapeutic success was evaluated by assessing the survival rate on day 10, the neurological score of the surviving rabbits and Kaplan-Meier curves for long-term survival past 10 days. Inclusion of fenbendazole in the treatment protocol was associated with increased survival rates on day 10 (p=0.043), better neurological scores (p=0.008), and improved long-term survival (p=0.025) based on the results of univariate analyses. Treatment with dexamethasone showed no effect on neurological score or on short- or long-term survival. The study did not provide any evidence that dexamethasone is an effective component of the treatment scheme.     

Equine Embryo Biopsy,Genetic Testing,and Cryopreservation

Embryo cryopreservation and embryo biopsy have been slow to become established in equine reproductive practice, partly because of the difficulty in applying these techniques to the equine embryo as it is typically recovered from the uterus, that is, at day 7 after ovulation as an expanded blastocyst. Over the past 5 years, we have developed a technique, using micromanipulation with the Piezo drill, which provides a method for biopsy of both small and large equine embryos, with accurate genetic diagnosis from the biopsied cells and normal pregnancy and foaling rates after transfer. During the development of this biopsy technique, we found that blastocysts collapsed after biopsy showed relatively high viability after vitrification and warming. Modification of vitrification methods allowed the establishment of a vitrification technique that supports normal pregnancy rates for expanded blastocysts up to 650 μm in diameter. This technique uses blastocyst collapse, vitrification medium containing ethylene glycol and galactose, in combination with warming medium containing sucrose, and a low-volume vitrification device. Biopsy and vitrification of expanded equine blastocysts are now offered commercially, and have the potential to become valuable tools for use by the equine practitioner in the efficient management of equine reproduction.     

Clinical Course of Acute Canine Polyradiculoneuritis Following Treatment with Human IV Immunoglobulin

Treatment of dogs with acute canine polyradiculoneuritis (ACP) is restricted to physical rehabilitation and supportive care. In humans with Guillain-Barré syndrome, the counterpart of ACP, randomized trials show that IV immunoglobulin (IVIg) speeds recovery. The authors of the current study hypothesized that dogs with ACP would tolerate IVIg well and recover faster than dogs managed with supportive treatment only. Sixteen client-owned dogs with ACP were treated with IVIg, and 14 client-owned dogs served as a retrospective control group. Diagnosis was confirmed using clinical features, electrodiagnostics, cerebrospinal fluid analysis, and muscle/nerve biopsies. The duration of the initial progressive phase, the time from IVIg administration until the dogs were ambulating without assistance, and the duration of the complete episode were evaluated. Adverse reactions (anaphylaxis, mild hematuria) were observed in two dogs. Dogs treated with IVIg were ambulating without assistance after a median of 27.5 days (range, 15-127 days) from onset of clinical signs. The control group was ambulatory without assistance at a median of 75.5 days (range, 5-220 days). Even though this result is not statistically significant, there is a clear trend toward faster recovery in dogs treated with IVIg.     

Effect of feeding increasing quantities of starch on glycaemic and insulinaemic responses in healthy horses

The aim of this study was to investigate the effect of increasing the intake of starch on the glycaemic and insulinaemic responses of horses. A cross-over study design was used in which four horses were fed increasing amounts of a compound feed (0.5–3.5 kg) to provide 0.3, 0.6, 0.8, 1.1, 1.4 and 2 g starch/kg bodyweight (BW)/meal. The glycaemic response increased with starch intake (P < 0.05), while feeding <1.1 g starch/kg BW resulted in a lowered response, compared to when 1.1–2 g starch/kg BW was fed (P < 0.01). The results suggested that insulin responses may be more appropriate to define the effect of feeding different starch levels than glycaemic responses. A starch intake of <1.1 g/kg BW/meal produced only moderate glucose and insulin responses, even though highly processed cereals were used. It is therefore recommended that a starch intake of <1.1 g/kg BW/meal or a meal size of 0.3 kg/100 kg BW (starch content of 30–40%) is used for horses.     

Time trends and seasonal variation of iodine content in German cow's milk--investigations from Northrhine-Westfalia

Cow's milk is one of the most important iodine providers in the human diet. The milk iodine content (MIC) is significantly determined by cattle feeding. The aim of the study was to investigate the longitudinal development of the MIC of German cow's milk during the last years and to assess the current contribution of milk consumption to the population's iodine supply. MIC was analysed by a Cer-Arsenit method after alkaline wet washing in 112 milk samples from nationwide available trademarks (eight samples each were purchased in June and December from 2004 onward to 2010 in the same food markets in the greater Dortmund area). We found an increasing trend of MIC until 2010 (p < 0.005).The mean MIC in 2004/05 was 97 +/- 32 microg/I, in 2009/10 it was 110 +/- 36 microg/l. This increase was only observable for conventionally (p = 0.0003), and not for organically produced milk (p = 0.6). The MIC of summer milk was about 22 microg/l lower than that of winter milk (p < 0.0001), however, seasonal variation was especially pronounced in organically produced milk. MIC of organically produced milk was in average about 54 microg/l lower than that of conventionally produced milk (p < 0.0001). Thus, the moderate increase of MIC to 110 microg/l on average contributes to the maintainence of the population's iodine supply, whereas the analysed maximum iodine contents of around 160 microg/l do not give reason to expect an excessive iodine intake, even in case of a high milk consumption. An appropriate iodine supplementation in foodstuff can be assumed.     

Layout proposal for a microtitre plate to be used in routine antimicrobial susceptibility testing of bacteria from infections of dogs and cats

The determination of minimum inhibitory concentrations by broth microdilution is recommended as method of choice for susceptibility testing of veterinary bacterial pathogens. Accordingly, broth microdilution is used in veterinary routine diagnostic laboratories at a progressive rate. To reduce the costs of susceptibility testing, it is reasonable to develop widely accepted uniform microtitre plate layouts that are produced in large quantities. Such microtitre plate layouts have already been developed and published for the susceptibility testing of pathogens from food-producing animals. However, a microtitre plate layout, especially designed for the testing of bacteria from dogs and cats, should be available, too. The choice of the antimicrobial agents or combinations of antimicrobial agents to be included in a suitable layout should be based on the following criteria: (1) the approval and availability of an antimicrobial agent or combination of agents, (2) known cross-resistances, and (3) availability of approved clinical breakpoints. The latter point is of particular importance for the choice of the numbers of concentrations per antimicrobial agent tested and the range of test concentrations. Taking into account these aspects, a science-based layout proposal for microtitre plates, which are suitable for routine testing of bacteria from dogs and cats, is presented and discussed.     

Treatment of cats with feline infectious peritonitis

Feline infectious peritonitis (FIP) infection resulting in clinical signs is invariably fatal despite clinical intervention. As FIP is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression but do not produce a cure. In nearly every published case report of attempted therapy for clinical FIP, glucocorticoids have been used; there are, however, no controlled studies that evaluate the effect of glucocorticoids as a therapy for FIP. Some veterinarians prescribe immune modulators to treat cats with FIP with no documented controlled evidence of efficacy. It has been suggested that these agents may benefit infected animals by restoring compromised immune function, thereby allowing the patient to control viral burden and recover from clinical signs. However, a non-specific stimulation of the immune system may be contraindicated as clinical signs develop and progress as a result of an immune-mediated response to the mutated FCoV.